MedPath

Metabolomic Fingerprint After Bariatric Surgery

Completed
Conditions
Obesity
Registration Number
NCT02480322
Lead Sponsor
eSwiss Medical & Surgical Center
Brief Summary

Background: Obesity is associated with multiple diseases. Bariatric surgery is the most effective therapy for severe obesity that cannot only reduce body weight but also obesity-associated morbidity.

Objective: The metabolic alterations associated with obesity and respective changes after bariatric surgery are incompletely understood.

Design: In the longitudinal observational study, the investigator applied a 1H-NMR-based global, untargeted metabolomics strategy on human serum samples that were collected before and repeatedly up to one year after distinct bariatric procedures (sleeve gastrectomy, proximal and distal Roux-en Y gastric bypass; RYGB). For comparison, the investigator also analyzed serum samples from normal-weight and less obesity obese subjects that were matched for 1-year postoperative BMI values of the surgical groups.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
106
Inclusion Criteria
  • BMI >/=35 kg/m2
  • at least 2 years of unsuccessful conservative weight loss attempts
Exclusion Criteria
  • < 18 years of age
  • BMI < 35 kg/m2
  • informed consent was not signed by the patient

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
compare the NMR metabolic fingerprint as assessed in serum samples of severely obese patients with that of normal-weight control subjectspre operative
follow up changes in the metabolic fingerprint over one year after 3 distinct bariatric procedurespre operative, 3-, 6-, 9- and 12 months post operative
compare the metabolic fingerprints established one year after the different surgeries with those of BMI-matched and normal-weight control subjects12 months post operative
Secondary Outcome Measures
NameTimeMethod

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.